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confounding factors, multivariate analysis show that LFLG AS was indepen-
dently associated with reduced long-term survival: HR= 2.02; 95 CI: (1.31-
3.15) p=0.002. Patients who underwent AVR had significantly better long-
term survival than those who were managed medically (70 pts) (all p< 0.001)
in all our 4 groups of severe AS patients irrespective of the gradient or flow.
Conclusion: Our cardiac catheterization-based study confirms that LFLG
severe AS is a frequent entity associated with poor both short- and long-term
outcome. Of interest, AVR seems to be a beneficial therapeutic option, even
in patients with LFLG pts.
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Background: Calcific aortic stenosis (CAS) is seen in a large proportion
of individuals after 60 years (yrs). Various biomarkers (BMs) are studied, as
regards mechanisms, diagnosis and prognosis. We studied some pertinent
markers expressing divergent processes.
Patients-Methods: We prospectively studied the following BMs in 60 pts
with CAS and compared them to 20 C free from any cardiac disease: Fetuin-
A (Fet), a calcification inhibiting glycoprotein, Sclerostin (SOST) and OPN,
calcification markers, metalloproteinase-2 (MMP-2) which promotes collagen
degradation, Tenancin C a tissue collagen formation protein, and IL-2 and
TNFa, inflammatory markers. Mean±SD of pts vs C was assessed.
Results: The age of pts with CAS was higher than than that of C
(66.1±12.5 vs 34.4.0±7.5 yrs, P<0.001). As regards BMs in CAS pts Fet was
not different from C (476.0±118.0 vs 481.1±83.03 μg/ml, NS); SOST was sig-
nificantly higher (2.59±0.79 vs 0.8±0.43 ng/ml P<0.005), as well as OPN
(23.02±11.6 vs 17.26±5.5 ng/ml P=0.019). MMP-2 was also higher
(8.65±1.67 vs 0.48±0.22 ng/ml, P<0.001), as well as Tenascin C (67.1±25.9
vs 48.03±24.9 ng/ml, P<0.001); IL-2 (968.2±399.5 vs 755.7±118.6 pg/ml,
P=0.001) and TNFa (16.23±11.8 vs 2.75±3.3 pg/ml, P<0.0001). Additionally,
preliminary findings show that Toll-like-receptors (TLR) are increased: TLR2
19.5±1.0, 10pts vs 0.6±0.2 ng/ml, 4 C, (p<0.001), and TLR7 36.6±5.4 vs
0.6±02,(p<0.03).
Conclusions: We found that many BMs expressing calcification, collagen
breakdown and formation and inflammation are increased in the serum of pts
with CAS as compared to controls. These data may contribute towards diag-
nosis, prognosis and potential treatment of this entity.
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Background: Transthoracic echocardiography (TTE) is the reference tech-
nique for evaluating aortic stenosis (AS), but in certain cases, estimation of the
average gradient and aortic valve area can be difficult. We aimed to assess the
feasibility and utility of measuring simultaneous transaortic pressure using a
fractional flow reserve (FFR) guidewire in doubtful aortic stenosis.
Method: Between January 2009 and December 2011, 57 patients with
symptoms possibly related to severe AS that was poorly evaluated by echocar-
diography underwent right and left heart catheterization for assessment of
aortic valve area with the Gorlin & Gorlin formula. Transaortic pressure was
obtained by 2 invasive methods, namely conventional pullback method from
the left ventricle (LV) towards the aorta (PM) with subsequent computerized
superposition of the pressure curves, and (2) simultaneous method using a
FFR wire introduced into the LV (SM).
Results: Reasons for inaccurate assessment by echocardiography were atrial
fibrillation (75%) and/or low LV ejection fraction (38%). Results of evaluation
of mean aortic valve gradient and aortic valve area are summarized in the table
below. Agreement between methods (using the kappa coefficient) for severe
aortic stenosis defined by an aortic-valve area < 0.6 cm²/m² was 0.36 between
SM and PM, 0.07 between SM and TTE, and –0.12 between PM and TTE. These
findings led to a decision to change therapeutic strategy in 8 patients (14%).
Conclusions: Simultaneous measurement of trans-aortic pressure using a
FFR guidewire is feasible and may be an attractive and accurate method for
evaluation of doubtful aortic stenosis.
Table – Results
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Background: Coronary artery disease (CAD) can be associated with aortic
stenosis (AS). Conventional coronary angiography (CCA) is the best method for
ruling out significant CAD when surgery is planned. However, significant per-
centage of patients had normal coronary arteries. New non invasive methods are
needed to select patients undergo CCA and reduce risks of this invasive exam.
Figure – Survival KM curve
SM PM TTE
Mean aortic valve gradient, mmHg  30.5±14.4  23.6±9.9  28.8±8.0
p vs PM  <0.0001  –  0.0002
p vs TTE  0.241  – –
Aortic valve area, cm/m²  0.46±0.2  0.48±0.15  0.49±0.1
p vs PM  0.003  – 0.529
p vs TTE  0.074  – –
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Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an inflammatory biom-
arker secreted in the atherosclerotic plaque. The main objective of this study is
to compare Lp-PLA2 with CCA in AS-patients prior to aortic valve surgery and
to evaluate Lp-PLA2 as an independent predictor of associated CAD.
Methods and Results: 285 patients with AS and/or CAD were included
into 3 groups: “CAD-Group”: stable CAD; “AS-Group”: AS and normal cor-
onary arteries and “AS-CAD-Group”: AS and stable CAD associated. Lp-
PLA2 mass concentration was assessed in serum with a Plac®-test turbidi-
metric immunoassay. Normal Lp-PLA2 values of the lipids laboratory were
specifically obtained from 61 healthy Caucasian volunteers.
In healthy controls, Lp-PLA2 was 163±43 μg/L. Lp-PLA2 was signifi-
cantly higher in patients than in controls (219.2±49.1 vs 163.0±43.0 μg/L;
p=0.01) and was significantly higher in the AS-CAD group (246±51 μg/L,
p<0.001) than in the 2 other groups (AS: 217±44; CAD: 215±48 μg/L). Lp-
PLA2 appeared to be an independent prognostic factor for CAD in patients
with AS (total r=0.76; p=0.005) with a rule-out value of 230 µg/L. Lp-PLA2
was found to have 80.1% sensitivity, 58.6% specificity to separate AS with or
without CAD, while PPV and NPV were 70% and 58%, respectively.
Conclusion: Our results suggest that in patients with severe AS, Lp-
PLA2 could correlate with associated stable CAD, with a rule-out value of
230 µg/L, and may be helpful to select patients requiring coronary angio-
graphy before cardiac valve surgery.
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Objectives: The purpose of this study was to evaluate the efficacy and
safety of transcatheter aortic valve implantation (TAVI) in patients with small
body size (SB).
Background: Clinical outcome of TAVI in patients with SB remains unclear.
Methods: Between October 2006 and November 2011, 424 patients with
severe aortic stenosis undergoing TAVI were evaluated. The cohort with small
body surface area of <1.75 m2 was defined as the “SB group” (n=215) and the
rest of the cohort with large body-size as the “LB group” (n=209). 
Results: In the SB group, the aortic annulus and femoral artery diameter
were significantly smaller (23.0±1.86 vs 24.3±1.94 mm, p <0.001; 7.59±1.06 vs
8.29±1.34 mm, p <0.001, respectively). The logistic EuroSCORE was similar
between the groups (22.5±10.4 vs 23.4±12.0, p=0.433). Equivalent device suc-
cess (91.2 vs 91.4%, p=0.935) and 30-day survival rates (85.1 vs 87.6%,
p=0.464) were achieved in both groups. Vascular complications were signifi-
cantly higher in the SB group (13.0% vs 4.3%, p=0.002). Similar post-proce-
dural mean pressure gradient was achieved in both groups (10.2±4.3 vs 11.0±4.6
mmHg, p=0.119). Kaplain-Meier survival analysis revealed no significant dif-
ference in the mid-term survival between groups (log-rank p=0.642). 
Conclusions: TAVI in patients with SB resulted in similar clinical out-
comes with effective post-procedural hemodynamics compared with LB. Care
should be taken to avoid vascular complication in patients with SB.
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In recent studies, the impact of a low or high body mass index (BMI)
on outcome after cardiac surgery has been the subject of controversy. Our
study was conducted to determine the influence of BMI on late mortality
after aortic valve replacement (AVR) in pts with significant aortic stenosis
(AS).
Methods: 1150 pts (42% women, mean age of 6510 yrs) were observed
mean 7,54 yrs (40 days to 13 yrs) after AVR due to significant, isolated
AS (99% complete). BMI was divided in three groups: <25 kg/m2
(478 pts), 25-30 kg/m2 (472 pts) and >35 kg/m2 (200 pts). During 10 yrs
221 deaths were recorded – 70 women (14,6%) and 151 men (22,7%) –
p=0,001. 
Results: Kaplan-Meier analysis of survival was assessed. The differences
were observed in whole group (0,04) and in men (p=0,001) but not in women
(NS). Male patients with BMI <25 and>30 kg/m2 had higher risk of death in
comparison to those with BMI 25-30 kg/m2.
Conclusion: The survival after aortic valve replacement is related to body
mass index only in male patients – BMI <25 kg/m2 and >30 kg/m2 is predic-
tive of an increased risk of late mortality.
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It has been shown during the past few years that woman’s heart is different
than man’s. It is stressed, that women are on increased risk of aortic valve
replacement (AVR) due to greater hypertrophy and worse its regression.
Objective: The aim of the study was to estimate whether the survive after
AVR is gender related or there are any other parameters which have impact
on follow up after surgery in aortic stenosis (AS). 
Methodology: 993 pts (408 women, age 65±10 yrs) after AVR due to AS
were observed mean 7,5±4 yrs after surgery. Following parameters were taken
into account: gender, age, significance of AS (transaortic gradient – MAG),
left ventricle hypertrophy (mass index- LVMI), ejection fraction (EF) and
presence of coronary artery stenosis (CAD) assessed before AVR.
Figure
